ALORA Side Effects

6920979-3 | Blood Prolactin Increased, Galactorrhoea, Gynaecomastia, Prolactinoma
on Aug 02, 2010 Male patient from BRAZIL , 42 years of age, was treated with Alora (View Usage). Patient experienced the following unwanted or unexpected effects: blood prolactin increased, galactorrhoea, gynaecomastia, prolactinoma. Alora dosage: 10 Mg Im Every 15 Days.

5702905-8 | Scratch
Patient was taking Alora (View Usage). Patient had the following side effects: scratch on Apr 10, 2008 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 145.0 lb, . Alora dosage: 00.1 2x Weekly.

5660290-4 | Deep Vein Thrombosis, Oedema Peripheral
Adverse event was reported on Sep 19, 2007 by a Female patient taking Alora (View Usage) (Dosage: 1 Patch, 2/week, Transdermal ; 1 Patch, 2/week, Transdermal) . Location: UNITED STATES , 48 years of age, After Alora was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), oedema peripheral.

5273533-6 | Blister
on Mar 21, 2007 Male patient from UNITED STATES , 50 years of age, weighting 190.0 lb, was treated with Alora (View Usage). Patient experienced the following unwanted or unexpected effects: blister. Alora dosage: 1 Patch Twice Weekly At Least 2 Years. During the same period patient was treated with CARDIZEM (View Cardizem Review and Cardizem Label ), BENICAR HCT (View Benicar Hct Review and Benicar Hct Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LUNETSA (View Lunetsa Review and Lunetsa Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), PRILOSEC (View Prilosec Review and Prilosec Label ).


4976931-0 | Breast Cancer Female, Breast Disorder Female, Breast Pain, Breast Swelling, Breast Tenderness, Hypertrophy Breast
on Apr 05, 2006 Female patient from UNITED STATES , 63 years of age, was treated with Alora (View Usage). Patient had the following side effects: breast cancer female, breast disorder female, breast pain, breast swelling, breast tenderness, hypertrophy breast. Alora dosage: 1 Patch, 2/week, Transdermal. During the same period patient was treated with MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ), VICOPROFEN (View Vicoprofen Review and Vicoprofen Label ), ATIVAN (View Ativan Review and Ativan Label ).

4972259-3 | Asthenia, Brain Stem Infarction, Ear Discomfort, Hypertension, Hypoaesthesia, Menorrhagia, Vertigo
Patient was taking Alora (View Usage). After Alora was administered, patient had the following side effects: asthenia, brain stem infarction, ear discomfort, hypertension, hypoaesthesia, menorrhagia, vertigo on Oct 14, 2005 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 125.0 lb, was diagnosed with osteoporosis (What is osteoporosis?) and. Alora dosage: See Image, Transermal. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), NORVASC (View Norvasc Review and Norvasc Label ). Patient was hospitalized.

4787272-9 | Lymphangioleiomyomatosis
Adverse event was reported on Sep 21, 2005 by a Female patient taking Alora (View Usage) (Dosage: 1 Month, Transdermal) . Location: SPAIN , 59 years of age, Patient experienced the following unwanted or unexpected effects: lymphangioleiomyomatosis. During the same period patient was treated with PROGESTERONE TRANSDERMAL PATCH (View Progesterone Transdermal Patch Review and Progesterone Transdermal Patch Label ). Patient was hospitalized.